Associate Professor Galatea Kallergi is a leading researcher in the field of cancer biology, with a specialized focus on liquid biopsy, circulating tumor cells (CTCs), and metastatic signaling. Based at the Department of Biology, University of Patras, Greece, she brings over two decades of experience in translational oncology. Her pioneering work has contributed significantly to understanding the molecular and phenotypic characteristics of CTCs and their role in cancer progression, drug resistance, and immune evasion. With an extensive publication record, international collaborations, and expertise in both fundamental and applied cancer research, Professor Kallergi is committed to mentoring the next generation of scientists in precision oncology.
This 6-week onsite fellowship, hosted at the University of Patras by Associate Professor Galatea Kallergi, offers a focused exploration of liquid biopsy technologies in cancer research, with a strong emphasis on Circulating Tumor Cells (CTCs) and Extracellular Vesicles (EVs). Fellows will gain in-depth exposure to cutting-edge techniques for isolation, phenotypic characterization, molecular profiling, and drug response testing using patient-derived samples. The program integrates theoretical grounding with practical lab training and is ideal for those interested in translational oncology, metastasis research, and the development of precision medicine strategies.
Areas of interest
Overview of Liquid Biopsy (LB)
Types of analytes:
- Circulating Tumor Cells (CTCs)
- Extracellular Vesicles (EVs)
1. Characteristics and properties of CTCs and EVs
2. Role of CTCs and EVs in cancer progression, metastasis, and disease monitoring
Liquid Biopsy Applications in Cancer Research
- Isolation and molecular characterization of CTCs and EVs for disease monitoring
- Integration of LB techniques to inform treatment decisions and enhance patient outcomes
- Advancing precision oncology through the use of liquid biopsy in personalized medicine
Specialties
- Liquid Biopsy
- Circulating Tumor Cells (CTCs)
- Extracellular Vesicles (EVs)
- Cancer Metastasis
- Precision Oncology